SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,900,000 | +19.5% | 55,700 | +3.8% | 0.08% | +9.3% |
| Q2 2020 | $9,121,000 | +58.1% | 53,680 | +7.4% | 0.08% | +47.1% |
| Q1 2020 | $5,768,000 | +70.7% | 49,987 | +69.0% | 0.05% | +82.1% |
| Q4 2019 | $3,379,000 | +34.9% | 29,577 | +0.8% | 0.03% | +21.7% |
| Q3 2019 | $2,505,000 | -17.4% | 29,337 | -33.1% | 0.02% | +21.1% |
| Q2 2019 | $3,033,000 | -4.1% | 43,827 | +1.4% | 0.02% | -5.0% |
| Q1 2019 | $3,164,000 | +30.2% | 43,207 | +0.7% | 0.02% | +11.1% |
| Q4 2018 | $2,431,000 | -27.0% | 42,908 | -0.5% | 0.02% | -14.3% |
| Q3 2018 | $3,328,000 | +107.1% | 43,134 | +78.2% | 0.02% | +23.5% |
| Q2 2018 | $1,607,000 | +213.3% | 24,207 | +147.2% | 0.02% | +30.8% |
| Q1 2018 | $513,000 | – | 9,792 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |